Karacin, C. Et Al. 2023. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.. BMC cancer , vol.23, no.1 , 136.

Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... Selvi, O.(2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.. BMC cancer , vol.23, no.1, 136.

Karacin, Cengiz Et Al. "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.," BMC cancer , vol.23, no.1, 136, 2023

Karacin, Cengiz Et Al. "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.." BMC cancer , vol.23, no.1, pp.136, 2023

Karacin, C. Et Al. (2023) . "Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.." BMC cancer , vol.23, no.1, p.136.

@article{article, author={Cengiz Karacin Et Al. }, title={Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.}, journal={BMC cancer}, year=2023, pages={136} }